STAGE II PANCREATIC CANCER AJCC V8
Clinical trials for STAGE II PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized immune cells tested to fight five tough cancers
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a personalized cell therapy called STIL101. The therapy involved growing a patient's own cancer-fighting immune cells (T-cells) from a tumor sample in a lab and then infusing them back. It was designed for…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test new drug duo to starve pancreatic cancer cells
Disease control OngoingThis early-stage study is testing the safety and best dose of a two-drug combination for people with advanced pancreatic cancer that has spread. The drugs work together to try to cut off a nutrient that pancreatic cancer cells need to survive. Researchers will enroll 15 patients …
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Sound waves supercharge cancer drugs in groundbreaking trial
Disease control OngoingThis study is testing a new method called sonoporation to see if it makes standard chemotherapy more effective for pancreatic cancer. Sonoporation uses ultrasound waves and tiny bubbles to help more of the chemotherapy drug get into the tumor. Researchers are comparing patients w…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New 'Smart Bomb' drug combo tested in tough pancreatic cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a new targeted drug, anetumab ravtansine, when combined with other cancer treatments. It is for people with advanced pancreatic cancer that has a specific marker called mesothelin. The goal is to see if these combinati…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC